Malaria is an infectious parasitic disease transmitted by a vector, female anopheles mosquito. Malaria produces recurrent attack of fever and chills.

Market Dynamics: Global Malaria Vaccine Market

Global malaria vaccine market is mainly driven by increase in R&D activities of companies to develop vaccines for malaria. In addition, funding of the government and non-profit organizations and presence of pipeline vaccines and their expected commercialization anticipated to bolster the market growth further.

A sample of this report is available upon request @

[URL]https://www.precisionbusinessinsights.com/market-reports/malaria-vaccine-market/#ulp-4H8Z4LpNMLEuOnnx[/URL]

Market Scope: Global Malaria Vaccine Market

Global malaria vaccine is segmented based on type of vaccine, target and distribution channel

Based on type of vaccine, global malaria vaccine market is segmented into

• Protein Vaccine

• DNA Vaccines

• Others

Based on target, global malaria vaccines market is segmented into

• Pre-Erythrocytic Stage

• Erythrocytic Stage

• Combined Vaccines

Market Summary: Global Malaria Vaccine Market

Global malaria vaccine market is expected to grow at significant rates owing to prevalence rates to malaria worldwide. According to World Health Organization, in August 2015, total 91 countries and areas had ongoing malaria transmission and approximately half of the world’s population is at the risk of malaria.

To view TOC of this report is available upon request @

[URL]https://www.precisionbusinessinsights.com/market-reports/malaria-vaccine-market/#ulp-c654SbFYO64MsOhu[/URL]

Regional Analysis: Global Malaria Vaccine Market

Geographically, malaria vaccine market is segmented into Latin America, Europe, Asia- Pacific, North America, and the Middle East & Africa. The Middle East and Africa expected to grow at significant rates owing to the factors such as the prevalence of disease and growing awareness related to malaria vaccination, According to World Health Organization (WHO), in 2015, 90% of the malaria cases are from African Region alone.

Competition Assessment: Global Malaria Vaccine Market

Some of the key players in Malaria Vaccine market are GlaxoSmithKline Plc (U.K.), Sanaria Inc. (U.S.), Mymetics Corporation (Switzerland) and Novavax, Inc. (U.S.) to name a few.

Need more information about this report @

[URL]https://www.precisionbusinessinsights.com/market-reports/malaria-vaccine-market/#ulp-14mlyhjMGhVjZqa3[/URL]

Notable Market Developments: Global Malaria Vaccine Market

• In June 2016, Immunovaccine Inc. announced preclinical collaboration with University of Edinburgh’s Center for Immunity, Infection and Evolution for malaria

• In January 2013, Cadila Pharmaceuticals along with its partner Novavax Inc. collaborated with CPL Biologics to develop the novel malaria vaccine.

Key Features of the Report:

• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

• The report tracks recent innovations, key developments and startup’s details that are actively working in the market

• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Get access to full summary @

[URL]https://www.precisionbusinessinsights.com/market-reports/malaria-vaccine-market/[/URL]